Filing Details
- Accession Number:
- 0001209191-11-033761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-08 19:45:42
- Reporting Period:
- 2011-06-06
- Filing Date:
- 2011-06-08
- Accepted Time:
- 2011-06-08 19:45:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1080014 | Theravance Inc | THRX | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1032623 | M Jeffrey Drazan | Bertram Capital 800 Concar Drive, Suite 100 San Mateo CA 94402 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-06-06 | 37,344 | $23.08 | 78,251 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-06-07 | 31,907 | $23.29 | 46,344 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents sales of (i) 15,000 shares held personally by the Reporting Person and (ii) 22,344 shares held by Sierra Ventures Associates VI, L.P. as nominee for the Reporting Person.
- Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $23.00 to $23.23 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $23.25 to $23.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
